In the Original Investigation titled “Efficacy of Losartan in Hospitalized Patients With COVID-19–Induced Lung Injury: A Randomized Clinical Trial,”[1] published March 16, 2022, Nastasia James was missing from the list of Angiotensin Receptor Blocker Based Lung Protective Strategies for Inpatients With COVID-19 (ALPS-IP) Investigators. This article has been corrected.[1]
Authors: Michael A Puskarich; Nicholas E Ingraham; Lisa H Merck; Brian E Driver; David A Wacker; Lauren Page Black; Alan E Jones; Courtney V Fletcher; Andrew M South; Thomas A Murray; Christopher Lewandowski; Joseph Farhat; Justin L Benoit; Michelle H Biros; Kartik Cherabuddi; Jeffrey G Chipman; Timothy W Schacker; Faheem W Guirgis; Helen T Voelker; Joseph S Koopmeiners; Christopher J Tignanelli Journal: JAMA Netw Open Date: 2022-03-01